Prescribing Drugs to the Elderly

Similar documents
Pharmacology in the Elderly

COMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK

Biology of Aging. Faculty Disclosure. Learning Objectives. I have no relevant financial disclosures relative to the content of this presentation.

Falls most commonly seen in RACFs are due to tripping, slipping and stumbling (21.6%). Falling down stairs is relatively uncommon in

Geriatric Pharmacology

Preventing Falls in Older Adults A Matter of Safety

Aging Changes That Impact Medication Management

Medication Use in Older Adults

START, STOPP, Beers Oh My! Navigating the World of Geriatric Pharmacy

PRESCRIBING IN THE ELDERLY. CARE HOME PHARMACY TEAM Bhavini Shah, Eleesha Pentiah & Puja Vyas

Pharmaceutical Care for Geriatrics

PHARMACOTHERAPY IN THE OLDER PERSON NAMIRAH JAMSHED M.B;B.S ASSOCIATE PROFESSOR UTSW MEDICAL CENTER DALLAS

OBJECTIVES. Key issues in geriatric pharmacology. Effects of age on pharmacokinetics and pharmacodynamics

How to Teach About Drugs and Aging

Rational prescribing in the older adult. Assoc Prof Craig Whitehead

CHAPTER 2. GERIATRICS, SELF-ASSESSMENT QUESTIONS

1/21/2016 UPDATE ON THE AMERICAN GERIATRICS SOCIETY 2015 BEERS CRITERIA DISCLOSURE OBJECTIVES AGING GOALS BEERS CRITERIA

Aging and Geriatric Assessment March 31, 2008 Sharon Leigh, Pharm D. BCPS Providence ElderPlace

Chitra Fernando, MD March 18, 2008

Pharmacotherapy In Geriatrics: Cause For Concern

Self Assessment Question 1

POLYPHARMACY IN OLDER ADULTS AND BEERS CRITERIA UPDATE

SIFROL â. Contraindications Hypersensitivity to pramipexole or any other component of the product.

SUMMARY OF PRODUCT CHARACTERISTICS FOR BENZODIAZEPINES AS ANXIOLYTICS OR HYPNOTICS

STOPP and START criteria October 2011

There s A Pill For That (But should my patient be on it?) A Review of Tools for the Evaluation of Optimal Prescribing in Geriatric Patients

2/26/2015 PHARMACODYNAMICS OF AGING: NARROWING OF THE THERAPEUTIC INDEX IN THE FACE OF THERAPEUTIC OPPORTUNITY

Safe and Effective Use of. Psychotropic Drugs. Introduction. Psychotropic Drugs. Jun NAKAMURA

Polypharmacy. Polypharmacy. Suboptimal Prescribing in Older Adults. Kenneth Schmader, MD Professor of Medicine-Geriatrics

Prevention of Medication-Related Falls Through Appropriate Medication Use. Clay Sprouse, MEd., CPhT Piedmont Technical College

Prescribing and Pharmacokinetic Considerations in the Elderly

DIF: COGNITIVE LEVEL: Understanding (Comprehension) REF: p. 37 TOP: NURSING PROCESS: General MSC: NCLEX: Health Promotion and Maintenance

Delirium and Dementia

Medicine Related Falls Risk Assessment Tool (MRFRAT)

Geri-PARDY! (2015 Beers Criteria) Pharmacology Edition

Prescribing for older people

LACIPIL QUALITATIVE AND QUANTITATIVE COMPOSITION

2/25/2015 PHARMACODYNAMICS OF AGING: NARROWING OF THE THERAPEUTIC INDEX IN THE FACE OF THERAPEUTIC OPPORTUNITY OVERALL PRESCRIBING

Medication Reviews within Care Homes. Catherine Armstrong

Deprescribing Unnecessary Medications: A Four-Part Process

PACKAGE LEAFLET: Information for the patient. DIAZEPAM Tablets 5 mg Solution for injection 10 mg / 2 ml (Diazepam)

DEPRESCRIBING IN THE ELDERLY

SIFROL Composition Properties Indication

Cetirizine Proposed Core Safety Profile

Polypharmacy & De-prescribing In Older Adults

Safe Medication Use. Holly Divine, PharmD, CGP, CDE. University of Kentucky College of Pharmacy Department of Pharmacy Practice & Science

Geriatric Pharmacology. Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center

Variation in drug responses & Drug-Drug Interactions

Rebecca Rottman-Sagebiel, Pharm.D., BCPS Sharon Jung Tschirhart, Pharm.D., BCPS Geriatric Clinical Pharmacy Specialists STVHCS, Audie L.

The usual dose is 40 mg daily with amoxycillin 1.5 g (750 mg b.d.) for 2 weeks. Up to 2 g/day of amoxycillin has been used in clinical trials.

Friend or Foe? Review of the Regulations & Benefits: Risk Profiles of the Benzodiazepines

Smoking Cessation Pharmacotherapy Guidelines

DRUG THERAPY CHOICES FOR THE DEMENTED PATIENT Past, Present and Future

DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017.

Polypharmacy in Geriatrics

VI.2 Elements for a Public Summary

Maximizing Medication Safety UNIVERSITY OF HAWAII AUGUST 31, 2016

Pitfalls in Pharmacotherapy of Geriatrics

Katee Kindler, PharmD, BCACP

Introductory Clinical Pharmacology Chapter 32 Antiparkinsonism Drugs

Chapter 01 Introduction

Drug Interactions Year 2 Clinical Pharmacology

Pharmaceutical Interventions. Collaborative Model of Mental Health Care for Older Iowans Des Moines May 18, 2007

Medicine Related Falls Risk Assessment Tool (MrFRAT) User Guide for Age Related Residential Care Facility Staff in Hawke s Bay

Eplerenon Medical Valley + Eplerenon Stada

Drug dosing in Extremes of Weight

PRODUCT INFORMATION. Ammonium chloride is an expectorant that has an irritant effect on mucous membranes.

Polypharmacy: What the Nurse Practitioner Should Know Audrey M. Stevenson PhD, MPH, MSN, FNP-BC Las Vegas 2017

Polypharmacy: What the Nurse Practitioner Should Know Audrey M. Stevenson PhD, MPH, MSN, FNP-BC Nashville, TN 2017

Dementia and Fall Geriatric Interprofessional Training. Wael Hamade, MD, FAAFP

Deconstructing Polypharmacy. Alan B. Douglass, M.D. Director

PRESCRIBING PRACTICE IN DELIRIUM. John Warburton Critical Care Pharmacist

Definition and Statistics

Qualitative and Quantitative Composition

Antipsychotic Medications

NEW ZEALAND DATA SHEET ACUPAN TM. 3. PHARMACEUTICAL FORM White, round, biconvex, film-coated tablets (7 mm diameter) engraved APN on one face.

Basic Biopharmaceutics, Pharmacokinetics, and Pharmacodynamics

Potential Drug Dosing Variability in Women. Jim Beaulieu, PharmD Senior Clinical Pharmacist Specialist Rhode Island Hospital and The Miriam Hospital

Family Medicine for English language students of Medical University of Lodz. Seminar 12. Elderly care. Przemysław Kardas MD PhD

CLINICAL PROTOCOL THE PREVENTION OF FATALITIES FROM MEDICATION LOADING DOSES

Polypharmacy and Common Drug Interactions in Geriatric Patients

European PSUR Work Sharing Project CORE SAFETY PROFILE. Lendormin, 0.25mg, tablets Brotizolam

Dementia NICE Guidelines Update. Key points for primary care - NICE guideline (June 2018 update ) 26 September 2018

PHARMACEUTICAL INFORMATION AZILSARTAN

M0BCore Safety Profile. Active substance: Bromazepam Pharmaceutical form(s)/strength: Tablets 6 mg FR/H/PSUR/0066/001 Date of FAR:

Acilight 75mg Tablets. Ranitidine Hydrochloride 83.57mg eq.to Ranitidine 75mg. Generic Name: Ranitidine Hydrochloride 83.57mg eq.

Interface Prescribing Subgroup DRUGS FOR DEMENTIA: INFORMATION FOR PRIMARY CARE

Principles of Medication Use in Older Adults ANNE L. HUME, PHARMD PROFESSOR OF PHARMACY UNIVERSITY OF RHODE ISLAND

Now available. A maintenance dose of SUBOXONE mg once daily is clinically effective for most patients*1. Once-daily dosing in a single tablet

Amal AL-Anazi, BSc.(Pharm) Medication Safety Officer In Eastern Region

Perfect Endings. Home Alone. Senior Estimate. Staying Alive. Medication Madness

Polypharmacy and the Older Adult. Leslie Baker, PharmD, BCGP Umanga Sharma, MD

The role of medication in falls risk

An approach to prescribing in the elderly. Preamble

Anthony J. Caprio, MD, CMD, AGSF 1

Pittsburgh CME Conference November 7-9, 2014

Psychotropic Drugs 0, 4-

What is the most important information I should know about midazolam?

STOPP START Toolkit Supporting Medication Review in the Older Person

How to prescribe The elderly. Andi Shirtcliffe Pharmacist

Transcription:

Answers to your questions from University of Toronto experts Prescribing Drugs to the Elderly Can drugs do more harm than good? M.A. is a 90-year-old man living at home. He has dementia and due to wandering tendencies, requires 24-hour supervision from his 85-year-old wife. His daughter convinces her mother to place him in respite care at a home for the aged, so the mother can go to Florida. Once placed in the new home, he becomes very agitated from being in a new environment. On the first day, he is given thioridazine and diazepam is added on the next day. While sedated from his medications, he falls and breaks his pelvis. He is rushed to an emergency department where he is started on oxycodone-acetylsalicylic acid. He subsequently develops massive upper gastrointestinal bleeding with aspiration. His wife returns from Florida just in time to see her husband die. cont d on the next page Please submit your questions to University of Toronto experts through The Canadian Journal of CME. Fax us at (514) 695-8554 or e-mail us at cme@sta.ca. The Canadian Journal of CME / March 2003 41

The elderly use about three times more drugs than their proportion in the population. In Ontario, almost 13% of its population is over 65, however, they use almost 40% of the drugs prescribed in the province. As the number of drugs prescribed increases, so do the chances for adverse drug reactions (ADRs). There has also been a marked increase in the use of non-prescription drugs. It shouldn t be forgotten that alcohol abuse is common in the elderly (Table 1). 1. Increased drug use Here are the main reasons for the increased use of drugs in the elderly: Table 1 Reasons for drug utilisation problems in the elderly 1. Increased drug use 2. Compliance 3. Altered pharmacokinetics 4. Altered pharmacodynamics (drug sensitivity) Few symptoms. Non-comprehension. Disability (i.e., visual, auditory, mental). No help or relatives at home. Cost. Prevalence of disease in the elderly. About 80% of the elderly have a chronic disease, compared to only 40% in people younger than 65. There are incorrect diagnoses. For instance, a tremor versus Parkinsonism. Lack of reassessment of drugs. Treatment of individual symptoms. Adding drugs without reassessing prior drugs. Sleep disturbances with aging. Behavioural problems associated with dementia. 2. Compliance The following items are the main factors that decrease compliance in the elderly. For ways to improve compliance in patients, see Table 2. Many drugs. Complicated regimens. It is estimated that about 20% of elderly patients receive at least one inappropriate drug. 3. Altered pharmacokinetics Pharmacokinetics are altered in the elderly in four areas: absorption, hepatic metabolism, including oxidation and conjugation, distribution, and renal excretion. The latter two are the most important. Absorption. There is no systematic decline in absorption with normal aging. However, with aging comes higher comorbidity, such as malabsorption and gastric/small bowel surgery, and the use of more drugs, such as gastric acid suppressants (i.e., omeprazole, ranitidine). Metabolism. In general, with age comes a decline in hepatic mass, the hepatic blood flow, and phase I reactions (i.e., cytochrome P-450 diazepam). However, phase II reactions remain relatively unchanged (i.e., drug conjugation and lorazepam). 42 The Canadian Journal of CME / March 2003

There are other more important factors than age that affect metabolism. Distribution. There are three key areas that change with age that affect the distribution of drugs in the body: body composition, concentration of plasma proteins and local blood flow (Table 3). As a person grows older, several changes in body composition take place. Normally, as a person ages, their total weight decreases, their lean body mass decreases, their total body water decreases and their total fat increases. Plasma proteins are also affected by aging. Albumin declines with disease rather than age, however, it is most common in the sick and elderly. If the patient is suffering from malnutrition, this can add to the problem. If, for instance, the patient were on phenytoin, problems would certainly occur because of the changes in plasma proteins. Elimination. Creatinine clearance declines on average 30% to 50% from age 40 to age 80. However, muscle mass also declines so that serum creatinine levels can seem normal. To properly calculate the creatinine, you can use the following formulas: Creatinine clearance (ml/min) = 1.23 x (140 age)(weight in kg)/creatinine or (umol/l) x 0.85 for females. Table 2 How to improve compliance Few drugs Simple regime Easy opening (avoid child proof packaging) Written instructions Explanation, use of dosette, etc Good labels This makes the interpretation of drug levels difficult. Helping Keep Your Patients Covered. 4. Pharmacodynamics End-organ responses to drugs are related to receptor/post-receptor events. There is no general rule since the elderly have varying sensitivities to different classes of drugs, for instance, there is greater sensitivity to sedatives, warfarin, and anticholinergics, however, there is less sensitivity to beta blockers. See page 3

Table 3 How age affects drug distribution An increase in total body fat A decrease in lean body mass and water A decrease in albumin An increase in alpha-1-glycoprotein An increase in volume distribution These will cause: An accumulation of lipophilic drugs, i.e., diazepam An increase in Vd of hydrophilic drugs An increase in peak serum concentration, i.e., ethanol An increase in binding acidic drugs, free drugs i.e., warfarin, phenytoin An increase in binding basic drugs i.e., lidocaine Adverse drug reactions Naturally, because of all these reasons, the elderly are more inclined to experience adverse drug reactions (ADRs). It has been estimated that 3% to 17% of hospitalisations are due to ADRs. As the number Table 4 Causes of falls and hip fractures Nearly 14% of hip fractures are associated with drugs that caused the patient to fall. These drugs include: Neuroleptics; Antidepressants (both TCAs and SSRIs); Benzodiazepines; of drugs used increases, so does the risk for an ADR. In fact, ADRs are more related to the number of drugs used rather than age itself. Hence, the fewer drugs prescribed to an elderly patient, the less likely for an ADR to occur. Common presentations of ADRs in the elderly are delirium, falls, urinary incontinence/retention, constipation/fecal incontinence, and misdiagnosis, which can lead to further inappropriate prescribing (Table 4). Drugdrug interactions rise exponentially with the amount of drugs used. Remember that over-thecounter drugs and herbals can cause ADRs, as well (i.e., gingko biloba affects warfarin, St- John s wort has sedating affects). Drugs that commonly cause ADRs can be given in various settings. In nursing homes, psychoactive drugs (sedatives/hypnotics, antidepressants, antipsychotics) and anticoagulants tend to be over-prescibed. In the community, numbers are less precise. It is estimated that about 20% of elderly patients receive at least one inappropriate drug. Physician drug reviews, with or without pharmacist input, improves these figures. Elderly people are particularly sensitive to drugs with anticholinergic effects (Table 5). Some effects and their consequences include: blurred vision, which can lead to falls and a decrease in functional ability; dryness and pain in the oral cavity, which can lead to malnutrition and can affect speech; there can be a worsening of symptoms and pain in the gastrointestinal tract; there can be an overflow in the urinary tract causing incontinence; postural hypotension can develop in the cardiovascular system; and there can be cognitive dysfunction in the central nervous system, especially in patients with Alzheimer s disease. Antihypertensives; and Anticholinergics. 44 The Canadian Journal of CME / March 2003

How to improve drug prescribing in the elderly Some good prescribing guidelines are to use drugs only when indicated, make a correct diagnosis, use as few drugs as possible, and to make sure the patient understands the drug regimen. This can be done by giving clear explanations, written instructions, dosettes and aids, and using relatives or helpers. Be wary of referring to lists of inappropriate prescribing, which helped define the rates of inappropriate prescribing in a variety of settings. These lists are arbitrary, consensus decisions, and only cover errors of commission without covering errors of omission. Ultimately, it is important to remember that when prescribing a drug to an elderly patient, the strength of its indication must be weighed against its potential for harm. CME Table 5 A sample of common drugs with anticholinergic effects Digoxin Diltiazem Furosemide Hydrochlorothiazide Nifedipine Warfarin Codeine Demerol Oxazepam Ranitidine Ampicillin Theophylline Diphenhydramine Hydroxyzine Triamterene Angiotensin II Receptor Blocker Angiotensin II Receptor Blocker/Diuretic Please consult product monographs for warnings and precautions. Product monographs available upon request at Sanofi-Synthelabo Canada Inc., 15 Allstate Pkwy, Markham, Ontario L3R 5B4. *Registered trademark of Sanofi-Synthelabo